搜索临床试验以:Radiopharmaceutical (131I-MIP-1095)
总计1291个结果
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.完全的
-
Sir Mortimer B. Davis - Jewish General Hospital终止前列腺肿瘤 | 前列腺癌 | 转移性前列腺癌 | 前列腺癌 | 转移性前列腺癌 | 软组织转移性前列腺癌加拿大
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Duke UniversityNational Institutes of Health (NIH)尚未招聘
-
Istanbul Medipol University HospitalÇanakkale Onsekiz Mart University; Mehmet Akif Ersoy Canakkale State Hospital完全的
-
The National Center on Addiction and Substance...National Institute on Drug Abuse (NIDA)完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.National Cancer Institute (NCI)撤销
-
Memorial Sloan Kettering Cancer CenterY-mAbs Therapeutics可用的
-
University of Texas Southwestern Medical Center不再可用
-
Molecular Insight Pharmaceuticals, Inc.终止
-
Y-mAbs Therapeutics终止
-
Precirix完全的
-
Children's Hospital of PhiladelphiaEli Lilly and Company; United States Department of Defense尚未招聘癌症 | 小儿癌症 | 分化型甲状腺癌 | 癌症, 甲状腺
-
Genzyme, a Sanofi Company完全的
-
Spinal Cord Injury Centre of Western DenmarkRigshospitalet, Denmark终止
-
Radboud University Medical Center未知
-
Progenics Pharmaceuticals, Inc.主动,不招人去势抵抗性前列腺癌 | 转移性前列腺癌 | 前列腺癌 | 前列腺肿瘤 | 进行性 mCRPC美国, 加拿大
-
Children's Hospital of PhiladelphiaBayer招聘中
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Northwell HealthCohen Children's Medical Center可用的
-
New Approaches to Neuroblastoma Therapy Consortium完全的
-
University Medical Center GroningenHealth Holland尚未招聘